Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer

被引:0
作者
Sadanori Watanabe
Akitada Yogo
Tsuguteru Otsubo
Hiroki Umehara
Jun Oishi
Toru Kodo
Toshihiko Masui
Shigeo Takaishi
Hiroshi Seno
Shinji Uemoto
Etsuro Hatano
机构
[1] Kyoto University,DSK Project, Medical Innovation Center, Graduate School of Medicine
[2] Cancer Research Unit,Department of Surgery, Graduate School of Medicine
[3] Sumitomo Pharma Co.,Department of Gastroenterology and Hepatology, Graduate School of Medicine
[4] Ltd,undefined
[5] Kyoto University,undefined
[6] Kyoto University,undefined
来源
BMC Cancer | / 22卷
关键词
Pancreatic cancer; Organoid; Peritoneal dissemination; Xenograft model; Compound screening;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 152 条
  • [1] Siegel RL(2021)Cancer statistics, 2021 CA Cancer J Clin 71 7-33
  • [2] Miller KD(2011)FOLFIRINOX versus gemcitabine for metastatic pancreatic Cancer N Engl J Med 364 1817-1825
  • [3] Fuchs HE(2013)Increased survival in pancreatic Cancer with nab-paclitaxel plus gemcitabine N Engl J Med 369 1691-1703
  • [4] Jemal A(2016)Pancreatic cancer Nat Rev Dis Prim 2 1-23
  • [5] Conroy T(2021)Treatment landscape of metastatic pancreatic cancer Cancer Treat Rev 96 102180-955
  • [6] Desseigne F(2019)Cancer modeling meets human organoid technology Science 364 952-338
  • [7] Ychou M(2015)Organoid models of human and mouse ductal pancreatic cancer Cell. 160 324-467.e6
  • [8] Bouché O(2018)Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression Cell Stem Cell 22 454-832
  • [9] Guimbaud R(2021)Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids Cell Stem Cell 28 816-26590
  • [10] Bécouarn Y(2019)Pancreatic cancer organoids recapitulate disease and allow personalized drug screening Proc Natl Acad Sci U S A 116 26580-1129